skip to Main Content


The use of increased levels of oxygen combined with increased atmospheric pressure has been recognized by mainstream medicine for use in fourteen conditions. At first glance these conditions are unrelated, yet they have two common attributes at some level – Hypoxia and Inflammation.

What makes HBOT the preferred therapeutic option?

There is an interesting relationship between hypoxia and inflammation. It is complex and bidirectional. Hypoxia, which refers to a deficiency in oxygen supply to tissues, can both contribute to and result from inflammation. Here’s a closer look at their relationship:

1. Hypoxia Induces Inflammation:

  • Hypoxia can trigger the release of pro-inflammatory signals and activate immune cells, leading to inflammation.
  • When tissues are deprived of oxygen, cells undergo metabolic changes, including the stabilization of hypoxia-inducible factor (HIF).
  • HIF activation leads to the production of various pro-inflammatory molecules, such as cytokines (e.g., interleukin-1, tumor necrosis factor-alpha) and chemokines, which attract immune cells to the site of inflammation.
  • Hypoxia-induced inflammation plays a role in various conditions, including ischemic diseases, chronic wounds, and inflammatory disorders.

2. Inflammation Causes Hypoxia:

  • Inflammation can disrupt the oxygen supply to tissues, leading to localized hypoxia.
  • During inflammation, blood vessels may become leaky, impairing oxygen delivery to the affected area.
  • Immune cells, such as neutrophils and macrophages, release reactive oxygen species (ROS) as part of the inflammatory response, which can damage surrounding tissues and further contribute to hypoxia.
  • Inflammatory cells also consume oxygen during their metabolic activities, further reducing local oxygen availability.
  • This localized hypoxia can perpetuate and sustain the inflammatory response, creating a cycle of inflammation and hypoxia.

Overall, hypoxia and inflammation are intertwined processes that can influence and amplify each other. Hypoxia can initiate and promote inflammation, while inflammation can cause localized hypoxia, perpetuating the inflammatory response. This interplay between hypoxia and inflammation is observed in various pathological conditions, and understanding their relationship is crucial for developing effective therapeutic strategies.

The application of oxygen under increased atmospheric pressure in hyperbaric oxygen therapy (HBOT) can interrupt the hypoxia inflammation cycle through several mechanisms.

Firstly, HBOT increases the amount of oxygen dissolved in the blood plasma, which enhances oxygen delivery to tissues, even in areas with compromised blood flow. This increased oxygen availability helps to alleviate tissue hypoxia, which is a key driver of the hypoxia inflammation cycle.

Secondly, HBOT promotes vasoconstriction in areas of tissue hypoxia. This constriction of blood vessels helps to redirect blood flow to areas with better oxygenation, improving tissue oxygenation and reducing local inflammation. By improving oxygen supply, HBOT interrupts the cycle of tissue hypoxia, which can trigger and sustain chronic inflammation.

Furthermore, HBOT has been shown to reduce the production of pro-inflammatory cytokines and increase the production of anti-inflammatory cytokines. Cytokines are signaling molecules that play a crucial role in the inflammatory response. By modulating the balance between pro-inflammatory and anti-inflammatory cytokines, HBOT helps to dampen the inflammatory response and prevent its perpetuation.

In addition, HBOT can enhance the activity of white blood cells, particularly neutrophils and macrophages, which are involved in the immune response and inflammation. By bolstering the immune system’s ability to clear pathogens and debris, HBOT can help resolve inflammation and prevent its chronic persistence.

Lastly, HBOT promotes the formation of new blood vessels, a process known as angiogenesis. This increased vascularization can improve tissue oxygenation and nutrient supply, further aiding in the resolution of inflammation and promoting tissue healing.

By interrupting the hypoxia inflammation cycle through these mechanisms, HBOT can have a profound impact on various conditions where chronic inflammation and tissue hypoxia are involved. These conditions include non-healing wounds, radiation injuries, certain infections, and ischemic conditions, among others.

It is important to note that the specific effects of HBOT on inflammation may vary depending on the condition being treated and individual patient factors. The application of HBOT should always be done under the guidance of trained healthcare professionals who can assess the patient’s specific needs and tailor the treatment accordingly.

Back To Top